X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
index medicus (45) 45
oncology (41) 41
chemotherapy (28) 28
cancer (24) 24
meta-analysis (20) 20
treatment outcome (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
female (18) 18
survival (18) 18
analysis (16) 16
randomized controlled trials as topic (16) 16
antineoplastic agents - therapeutic use (15) 15
breast cancer (14) 14
disease-free survival (13) 13
care and treatment (12) 12
male (12) 12
medicine & public health (10) 10
overall survival (10) 10
prognosis (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
breast neoplasms - drug therapy (9) 9
colorectal cancer (9) 9
colorectal neoplasms - drug therapy (9) 9
hematology, oncology and palliative medicine (9) 9
middle aged (9) 9
open-label (9) 9
pharmacology & pharmacy (8) 8
cetuximab (7) 7
clinical trials (7) 7
docetaxel (7) 7
lung neoplasms - drug therapy (7) 7
aged (6) 6
antineoplastic agents (6) 6
carcinoma, non-small-cell lung - drug therapy (6) 6
chemotherapy, adjuvant (6) 6
drug therapy (6) 6
efficacy (6) 6
erlotinib (6) 6
gastroenterology & hepatology (6) 6
hematology (6) 6
immunotherapy (6) 6
metastasis (6) 6
organoplatinum compounds - administration & dosage (6) 6
phase-ii trial (6) 6
phase-iii trial (6) 6
receptor, epidermal growth factor - antagonists & inhibitors (6) 6
risk factors (6) 6
survival analysis (6) 6
therapy (6) 6
antimitotic agents (5) 5
bevacizumab (5) 5
camptothecin - analogs & derivatives (5) 5
cancer patients (5) 5
cell lung-cancer (5) 5
colorectal neoplasms - pathology (5) 5
fluorouracil (5) 5
fluorouracil - administration & dosage (5) 5
gefitinib (5) 5
mutation (5) 5
oxaliplatin (5) 5
patients (5) 5
phase-ii (5) 5
phase-iii (5) 5
protein kinase inhibitors - therapeutic use (5) 5
systematic review (5) 5
toxicity (5) 5
urology (5) 5
urology & nephrology (5) 5
1st-line treatment (4) 4
adjuvant chemotherapy (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
antineoplastic agents - adverse effects (4) 4
breast neoplasms - mortality (4) 4
breast neoplasms - pathology (4) 4
colorectal neoplasms - mortality (4) 4
deoxycytidine - analogs & derivatives (4) 4
follow-up (4) 4
internal medicine (4) 4
irinotecan (4) 4
medical research (4) 4
metaanalysis (4) 4
metastases (4) 4
multicenter (4) 4
neoadjuvant chemotherapy (4) 4
neoplasm metastasis (4) 4
neoplasms - drug therapy (4) 4
pancreatic cancer (4) 4
pancreatic neoplasms - drug therapy (4) 4
panitumumab (4) 4
patient outcomes (4) 4
progression-free survival (4) 4
prospective studies (4) 4
radiotherapy (4) 4
randomized-trial (4) 4
research (4) 4
retrospective studies (4) 4
second line (4) 4
surgery (4) 4
survival rate (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Lung Cancer, ISSN 1525-7304, 03/2012, Volume 13, Issue 2, pp. 107 - 114
Advanced nonsmall-cell lung cancer (NSCLC) harboring activating mutations of epidermal growth factor receptor (EGFR) are particularly sensitive to tyrosine... 
Erlotinib | Nonsmall-cell lung cancer | Mutation | Gefitinib | EGFR
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 5, pp. 587 - 594
Journal Article
Journal Article
Acta Oncologica, ISSN 0284-186X, 07/2015, Volume 54, Issue 7, pp. 961 - 970
Abstract Background. In cancer cells, metabolism is shifted to aerobic glycolysis with lactate production coupled with a higher uptake of glucose as the main... 
TARGETED THERAPY | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | LONG-TERM SURVIVAL | 1ST-LINE CHEMOTHERAPY | TO-LYMPHOCYTE RATIO | LDH-A | RESISTANT PROSTATE-CANCER | PRETREATMENT SERUM-LEVELS | RENAL-CELL CARCINOMA | METASTATIC COLORECTAL-CANCER | Neoplasms - enzymology | Neoplasms - mortality | Neoplasms - blood | Prognosis | L-Lactate Dehydrogenase - blood | Humans
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2019, Volume 174, Issue 3, pp. 597 - 604
Several trials have demonstrated the benefit of anti-CDK4/6 inhibitors plus endocrine therapy in estrogen receptor-positive (ER+) advanced breast cancer (BC),... 
Oncology | Breast cancer | Medicine & Public Health | CDK-4/6 inhibitors | Meta-analysis | Estrogen | Online searching | Clinical trials | Diarrhea | Internet/Web search services | Metastasis | Database searching | Comparative analysis | Fulvestrant | Index Medicus
Journal Article
Journal Article
Journal Article